Clinical Trials Directory

Trials / Completed

CompletedNCT01832701

Coffee, Exercise, and Oxidative Stress

Coffee and Oxidative Stress During Exercise in Healthy Humans

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Coffee is one of the most widely consumed beverages. It contains polyphenols (chlorogenic acids) and bioavailability of these bioactive compounds is now somewhat well understood. In addition, chlorogenic acids are known to be antioxidants in the cup, but reliable evidence remains to be observed in vivo. The objective of this trial is to understand if regular (14d) coffee intake may be beneficial on biomarkers of oxidative damage measured in urine and plasma after an acute stress caused by exercise.

Detailed description

Coffee is one of the most widely consumed beverages. It contains polyphenols (chlorogenic acids) and bioavailability of these bioactive compounds is now somewhat well understood. However, even if chlorogenic acids are known to be antioxidants in the cup, reliable evidence remains to be observed in vivo. After medical examination and approval, subjects will undergo 2 periods of 21 days. The first 7 days will consist of a dietary restriction to lower the polyphenols intake. Then subjects will drink at random one of the three treatments for 14 days (4 cups/day). Blood and urine samples will be collected throughout the study to evaluate in vivo effects on oxidative biomarkers. Furthermore, at day 21, subjects will undergo a physical regimen to increase acutely and transiently their oxidative damage. Blood and urine samples collected throughout this challenge will allow us to evaluate the effect of coffee intake in reducing oxidative damage created by exercise compared to placebo.

Conditions

Interventions

TypeNameDescription
OTHERCoffeecoffee versus placebo
OTHERPlacebo comparatormaltodextrine with caffeine

Timeline

Start date
2012-03-01
Primary completion
2013-02-01
Completion
2013-06-01
First posted
2013-04-16
Last updated
2014-04-21

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01832701. Inclusion in this directory is not an endorsement.